Related references
Note: Only part of the references are listed.Interaction of vanadium(IV) with human serum apo-transferrin
Sameena Mehtab et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
VIVO and CuII complexation by ligands based on pyridine nitrogen donors
Daniele Sanna et al.
DALTON TRANSACTIONS (2012)
The anti-diabetic bis(maltolato)oxovanadium(IV) decreases lipid order while increasing insulin receptor localization in membrane microdomains
Peter W. Winter et al.
DALTON TRANSACTIONS (2012)
The potentiality of vanadium in medicinal applications
Dieter Rehder
FUTURE MEDICINAL CHEMISTRY (2012)
VO(dmpp)2 normalizes pre-diabetic parameters as assessed by in vivo magnetic resonance imaging and spectroscopy
Ana M. Metelo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum
Daniele Sanna et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Biotransformation of BMOV in the presence of blood serum proteins
Daniele Sanna et al.
METALLOMICS (2012)
The speciation of vanadium in human serum
Tamas Jakusch et al.
COORDINATION CHEMISTRY REVIEWS (2011)
Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components
J. Costa Pessoa et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Vanadate complexes in serum: a speciation modeling study
Tamas Jakusch et al.
DALTON TRANSACTIONS (2010)
New Developments in the Comprehension of the Biotransformation and Transport of Insulin-Enhancing Vanadium Compounds in the Blood Serum
Daniele Sanna et al.
INORGANIC CHEMISTRY (2010)
A quantitative study of the biotransformation of insulin-enhancing VO2+ compounds
Daniele Sanna et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Study of the antidiabetic capacity of the VO(dmpp)2 complex
Marta Passadouro et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Metallo-allixinate complexes with anti-diabetic and anti-metabolic syndrome activities
Hiromu Sakurai et al.
METALLOMICS (2010)
Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease
Lauren E. Scott et al.
CHEMICAL REVIEWS (2009)
Biospeciation of various antidiabetic (VO)-O-IV compounds in serum
Tamas Jakusch et al.
DALTON TRANSACTIONS (2009)
Interaction of VO2+ ion with human serum transferrin and albumin
Daniele Sanna et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin
Abdol-Khalegh Bordbar et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Novel 3-hydroxy-4-pyridinonato oxidovanadium(IV) complexes to investigate structure/activity relationships
Maria Rangel et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Vanadium compounds as therapeutic agents: Some chemical and biochemical studies
H. Faneca et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Vanadium treatment of type 2 diabetes: A view to the future
Katherine H. Thompson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Biospeciation of antidiabetic VO(IV) complexes
Tamas Kiss et al.
COORDINATION CHEMISTRY REVIEWS (2008)
Inhibition of protein tyrosine phosphatase 1B and alkaline phosphatase by bis(maltolato)oxovanadium (IV)
Ming Li et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
A rigid molecular balance for measuring face-to-face arene-arene interactions
William R. Carroll et al.
ORGANIC LETTERS (2008)
Study of thermal dynamics of defatted bovine serum albumin in D2O solution by Fourier transform infrared spectra and evolving factor analysis
Bo Yuan et al.
APPLIED SPECTROSCOPY (2007)
Vanadium in diabetes: 100 years from Phase 0 to Phase I
Katherine H. Thompson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Chemistry and biochemistry of insulin-mimetic vanadium and zinc complexes. Trial for treatment of diabetes mellitus
Hiromu Sakurai et al.
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN (2006)
Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones.: Rationalization of the influence of basicity and electronic structure of the ligand on the properties of VIVO species in aqueous solution
Maria Rangel et al.
INORGANIC CHEMISTRY (2006)
On the fate of vanadate in human blood
Andras Gorzsas et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2006)
Oxovanadium(IV) complexes with pyrazinecarboxylic acids:: The coordinating properties of ligands with the (Naromatic, COO-) donor set
Eugenio Garribba et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2006)
Metal complexes in medicinal chemistry: new vistas and challenges in drug design
KH Thompson et al.
DALTON TRANSACTIONS (2006)
The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor
HS Ou et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2005)
Quantum mechanical continuum solvation models
J Tomasi et al.
CHEMICAL REVIEWS (2005)
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): Transport and biotransformation of insulin-enhancing vanadium pharmaceuticals
BD Liboiron et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Synthesis and characterization of mononuclear oxovanadium(IV) complexes and their enzyme inhibition studies with a carbohydrate metabolic enzyme, phosphodiesterase I
M Mahroof-Tahir et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2005)
The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds
DC Crans et al.
CHEMICAL REVIEWS (2004)
Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS
MH Nagaoka et al.
ANALYST (2004)
Pharmacokinetic study and trial for preparation of enteric-coated capsule containing insulinomimetic vanadyl compounds: Implications for clinical use
H Sakurai et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2004)
Study of the oxidation products of the VO(dmpp)2 complex in aqueous solution under aerobic conditions:: comparison with the vanadate-dmpp system
MMCA Castro et al.
INORGANICA CHIMICA ACTA (2003)
Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium);: unliganded vanadium (VO4) as the active component
KG Peters et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
In silico prediction of drug-binding strengths to human serum albumin
G Colmenarejo
MEDICINAL RESEARCH REVIEWS (2003)
Regulation of tyrosine phosphorylation cascades by phosphatases: What the actions of vanadium teach us
P Hulley et al.
JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE (2003)
Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential
KH Thompson et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2003)
Design of iron chelators with therapeutic application
ZD Liu et al.
COORDINATION CHEMISTRY REVIEWS (2002)
Binding patterns of vanadium ions with different valence states to human serum transferrin studied by HPLC/high-resolution ICP-MS
MH Nagaoka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Fractionation of vanadium complexes in serum, packed cells and tissues of Wistar rats by means of gel filtration and anion-exchange chromatography
K De Cremer et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2002)
New developments in the polarizable continuum model for quantum mechanical and classical calculations on molecules in solution
M Cossi et al.
JOURNAL OF CHEMICAL PHYSICS (2002)
Binding of vanadate to human albumin in infusion solutions, to proteins in human fresh frozen plasma, and to transferrin
G Heinemann et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2002)
Antidiabetic vanadium(IV) and zinc(II) complexes
H Sakurai et al.
COORDINATION CHEMISTRY REVIEWS (2002)
Interaction between the low molecular mass components of blood serum and the VO(IV)-DHP system (DHP=1,2-dimethyl-3-hydroxy-4(1H)-pyridinone)
P Buglyo et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2002)
The systems (VO2+)-O-IV-glutathione and related ligands: a potentiometric and spectroscopic study
JC Pessoa et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2002)
6-carboxamido-5,4-hydroxypyrimidinones: A new class of heterocyclic ligands and their evaluation as gadolinium chelating agents
CJ Sunderland et al.
INORGANIC CHEMISTRY (2001)
In vitro study of the insulin-like action of vanadyl-pyrone and -pyridinone complexes with a VO(O4) coordination mode
M Rangel et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2001)
Pyridinone oxovanadium(IV) complexes: a new class of insulin mimetic compounds
M Rangel
TRANSITION METAL CHEMISTRY (2001)
Structural study of the interaction of vanadate with the ligand 1,2-dimethyl-3-hydroxy-4-pyridinone (Hdmpp) in aqueous solution
MMCA Castro et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2000)
Design of vanadium compounds as insulin enhancing agents
KH Thompson et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2000)
Share Paper
